Two Sigma Securities’s bluebird bio BLUE Stock Holding History

Two Sigma Securities’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-734	Closed	-$102K	–	2675
2022 Q4	$102K	Buy	+734	New	+$103K	﹤0.01%	2064
2020 Q1	–	Sell	-535	Closed	-$608K	–	1405
2019 Q4	$608K	Buy	+535	New	+$582K	﹤0.01%	1332
2019 Q2	–	Sell	-135	Closed	-$234K	–	2085
2019 Q1	$276K	Sell	135 -129	-49%	-$227K	﹤0.01%	1251
2018 Q4	$340K	Buy	+264	New	+$405K	﹤0.01%	1258
2017 Q3	–	Sell	-970	Closed	-$1.32M	–	936
2017 Q2	$1.32M	Buy	970 +712	+276%	+$859K	0.25%	64
2017 Q1	$304K	Buy	+258	New	+$263K	0.06%	360

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Two Sigma Securities's BLUE Position: Q1 2023 in Review

Two Sigma Securities sold out of bluebird bio (BLUE) in Q1 2023, closing a stake of 734 shares — an estimated $102K sold.

Two Sigma Securities first reported a position in BLUE in Q1 2017 and held it in 6 quarters. The position peaked at $1.32M in Q2 2017. 177 funds tracked by Wall St. Rank hold BLUE as of Q1 2023.

Two Sigma Securities reported no remaining bluebird bio position as of Q1 2023 after selling out during the quarter.
Two Sigma Securities sold 734 bluebird bio shares in Q1 2023, an estimated $102K.
Two Sigma Securities first reported a position in bluebird bio in Q1 2017 and held it in 6 quarters.
Two Sigma Securities's bluebird bio position peaked at $1.32M in Q2 2017.
177 funds tracked by Wall St. Rank held bluebird bio as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.